Impact of Fenfluramine on drop seizure frequency in adults or dose- capped patients with Lennox-Gastaut Syndrome: comparative analysis of clinical trial data

被引：0
作者：
Scheffer, I. E. [1 ]
Ceulemans, B. [2 ]
Sullivan, J. [3 ]
Nickels, K. C. [4 ]
Lagae, L. [5 ,6 ]
Guerrini, R. [7 ,8 ]
Zuberi, S. M. [9 ]
Nabbout, R. [10 ]
Riney, K. [11 ,12 ]
Polega, S. [13 ]
Lothe, A. [14 ]
Davis, R. [15 ]
Gil-Nagel, A. [16 ]
机构：
[1] Univ Melbourne, Austin & Royal Childrens Hosp, Melbourne, Australia
[2] Antwerp Univ Hosp, Dept Paediat Neurol, Antwerp, Belgium
[3] Univ Calif San Francisco, Benioff Childrens Hosp, Weill Inst Neurosci, San Francisco, CA USA
[4] Mayo Clin, Dept Neurol, Rochester, MN USA
[5] European Reference Network EpiCARE, Leuven, Belgium
[6] Univ Leuven, Dept Paediat Neurol, Leuven, Belgium
[7] Univ Florence, Anna Meyer Childrens Hosp, Pediat Neurol & Neurogenet Unit, Florence, Italy
[8] IRCCS Fdn Stella Maris, Pisa, Italy
[9] Royal Hosp Children, Paediat Neurosci Res Grp, Glasgow, Scotland
[10] Univ Paris Cite, Hop Univ Necker Enfants Malad, APHP,EPICARE, Reference Ctr Rare Epilepsies,Inst Imagine, Paris, France
[11] Queensland Childrens Hosp, Neurosci Unit, South Brisbane, Australia
[12] Univ Queensland, Sch Clin Med, St Lucia, Australia
[13] Zogenix Inc, Emeryville, CA USA
[14] Zogenix Int LTD, Maidenhead, England
[15] Neurol & Epilepsy Res Ctr, Orlando, FL USA
[16] Hosp Ruber Int, Madrid, Spain
来源：
EPILEPSIA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
735
引用
收藏
页码：8 / 8
页数：1
相关论文
共 40 条
[21]   Treatment with Cannabidiol (CBD) Significantly Reduces Drop and Total Seizure Frequency in Lennox-Gastaut Syndrome (LGS): Results of a Multicenter, Randomized, Double-blind, Placebo Controlled Trial (GWPCARE4) [J].
Joshi, C. ;
Thiele, E. ;
Marsh, E. ;
French, J. .
ANNALS OF NEUROLOGY, 2017, 82 :S293-S293
[22]   Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox-Gastaut syndrome (LGS): results of a dose-ranging, multi-center, randomized, double-blind, placebo-controlled trial (GWPCARE3) [J].
Patel, Anup ;
Devinsky, Orrin ;
Cross, J. Helen ;
Villanueva, Vicente ;
Wirrell, Elaine ;
VanLandingham, Kevan ;
Roberts, Claire ;
Checketts, Daniel ;
Zuberi, Sameer .
NEUROLOGY, 2017, 89 (08) :E100-E100
[23]   Seizure Outcomes With Cannabidiol (CBD) in Pediatric Versus Adult Patients With Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS): Subgroup Analysis of BECOME, a Caregiver Survey [J].
Saurer, T. ;
Berg, A. ;
Dixon-Salazar, T. ;
Meskis, M. ;
Danese, S. ;
Le, N. ;
Perry, M. .
ANNALS OF NEUROLOGY, 2023, 94 :S54-S54
[24]   Seizure Outcomes With Cannabidiol (CBD) in Pediatric Versus Adult Patients With Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS): Subgroup Analysis of BECOME, a Caregiver Survey [J].
Saurer, Timothy B. ;
Berg, Anne T. ;
Dixon-Salazar, Tracy ;
Meskis, Mary Anne ;
Danese, Sherry R. ;
Le, Ngoc Minh D. ;
Perry, M. Scott .
NEUROLOGY, 2023, 100 (17)
[25]   Seizure outcomes with cannabidiol (CBD) in pediatric versus adult patients with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS): Subgroup analysis of become, a caregiver survey [J].
Saurer, Timothy B. ;
Dixon-Salazar, Tracy ;
Berg, Anne T. ;
Meskis, Mary Anne ;
Danese, Sherry R. ;
Le, Ngoc Minh D. ;
Perry, M. Scott .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[26]   Lennox-Gastaut syndrome in adulthood: Long-term clinical follow-up of 38 patients and analysis of their recorded seizures [J].
Vignoli, Aglaia ;
Oggioni, Gaia ;
De Maria, Giovanni ;
Peron, Angela ;
Savini, Miriam Nella ;
Zambrelli, Elena ;
Chiesa, Valentina ;
La Briola, Francesca ;
Turner, Katherine ;
Canevini, Maria Paola .
EPILEPSY & BEHAVIOR, 2017, 77 :73-78
[27]   CANNABIDIOL (CBD) SIGNIFICANTLY REDUCES DROP AND TOTAL SEIZURE FREQUENCY IN LENNOX-GASTAUT SYNDROME (LGS): RESULTS OF A DOSE-RANGING, MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (GWPCARE3) [J].
Zuberi, S. ;
Devinsky, O. ;
Patel, A. ;
Cross, J. H. ;
Villanueva, V. ;
Wirrell, E. C. ;
Roberts, C. ;
Checketts, D. ;
van Landingham, K. .
EPILEPSIA, 2017, 58 :S13-S14
[28]   QUALITY OF LIFE IN PATIENTS WITH DRAVET SYNDROME OR LENNOX GASTAUT SYNDROME IN THE UK: HIGHER SEIZURE FREQUENCY HAS A SUBSTANTIAL NEGATIVE IMPACT ON QUALITY OF LIFE [J].
Radu, X. ;
Damera, V ;
Martin, M. ;
Simontacchi, K. ;
Holland, R. .
VALUE IN HEALTH, 2019, 22 :S346-S346
[29]   Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial [J].
Ohtsuka, Yoko ;
Yoshinaga, Harumi ;
Shirasaka, Yukiyoshi ;
Takayama, Rumiko ;
Takano, Hiroki ;
Iyoda, Kuniaki .
EPILEPSY RESEARCH, 2016, 121 :1-7
[30]   Caregiver-reported non-seizure and seizure outcomes with cannabidiol and clobazam in patients aged >2 years with Lennox-Gastaut syndrome or Dravet syndrome: A subgroup analysis of the BECOME survey [J].
Perry, M. Scott ;
Dixon-Salazar, Tracy ;
Meskis, Mary Anne ;
Danese, Sherry R. ;
Saurer, Timothy B. ;
Vyas, Kishan ;
Berg, Anne T. .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2025, 130 :32-40
1234